Heather Wilson, DPM, Joins Modern Foot & Ankle’s Sarasota Office
Dr. Wilson brings over two decades of private practice experience to Modern Foot & Ankle, with expertise in sports medicine,...
News
Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins
The company has achieved EBIDTA positive on a go-forward cash basis REDWOOD CITY, CA / ACCESSWIRE / October 3, 2024...
Dr. Robert Mignone of Penn Medicine Becker ENT & Allergy Selected as the First Aerin Medical Center of Excellence Provider for VivAer in NJ
Dr. Mignone's expert ENT approach brings innovative VivAer® nasal relief to New Jersey residents.ROBBINSVILLE, NJ / ACCESSWIRE / October 3,...
CBD Life Sciences, Inc. (CBDL) Launches First-of-Its-Kind CBD Horse Paste: A Veterinarian-Designed Solution for Equine Wellness
The annual economic impact of the equine industry is significant - involving some $300 billion dollars and 1.6 million full-time...
Infinx Launches Next-Generation Intelligent Automation Platform for Revenue Cycle Management
Improves Revenue Cycle Operations With AI-Powered Automations for Financial Clearance, Claims Processing, Credentialing and Payer WorkflowsCUPERTINO, CA / ACCESSWIRE /...
Solmetex(R) Offers Support to Dental Practices Affected by Hurricane Helene
MARLBOROUGH, MA / ACCESSWIRE / October 3, 2024 / As the leading experts in dental water solutions, Solmetex® is committed...
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe
Expansion adds new countries to Grovet's existing PulseVet distribution coverage and enables launch of the TRUFORMA® equine platform in Europe...
Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development
Drug Development & Delivery Publishes Overview of Obesity Formulation Development Results Demonstrating Significant Transdermal Penetration Using Invisicare Technology LAS VEGAS,...
AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis
Robert Edwards, MD, UPMC, Magee-Womens Hospital Robert Edwards, MD, UPMC, Magee-Womens Hospital Thomas Equels, CEO of AIM ImmunoTech Inc Thomas...
Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
SCOTTSDALE, Ariz., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage...
Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases
NEW YORK, Oct. 03, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Annovis Bio Inc. (NYSE: ANVS) announces the availability of a broadcast...
Kane Biotech to Participate in a Multinational Corporate Collaboration Project
WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”)...
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on...
Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate
The expansion of the strategic partnership reinforces the solid foundation of the collaborative efforts that commenced in April 2024The collaboration...
NMS Capital Portfolio Company Surplus Solutions Expands Internationally; Announces Partnership with FAMECO Group ApS
NEW YORK and STRASBOURG, France, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of...
Spectral AI Completes Proof of Concept for Wound Measurement Technology
Provides Clinicians with Superior Wound Size Measurement Information that Improves Patient Treatment DecisionsDALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Spectral...
Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
-- New J-code issued by the Centers for Medicare and Medicaid Services expected to standardize and streamline billing and reimbursement...
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at IDWeek 2024
JERSEY CITY, N.J., Oct. 03, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to...
Recent clinical data confirms significantly improved predictive power of Evaxion’s AI-Immunology™ platform
Improved precision of the AI-Immunology™ platform in predicting clinically relevant vaccine targets boosts the potential of its AI-derived vaccine candidates...
Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program
Former Eli Lilly Research Fellow Jeremy R. Graff, Ph.D., appointed as President and Chief Development Officer to lead the Company’s clinical...
